Esaote Sustainability Profile
Esaote S.p.A., a leading player in the medical imaging industry, is headquartered in Italy and operates extensively across Europe, Asia, and the Americas. Founded in 1982, Esaote has established itself as a pioneer in ultrasound and MRI technologies, focusing on innovative solutions for healthcare professionals. The company’s core products include advanced ultrasound systems, MRI machines, and dedicated software solutions, all designed to enhance diagnostic accuracy and patient care. Esaote's commitment to research and development has led to significant milestones, including the introduction of portable ultrasound devices that cater to diverse clinical environments. With a strong market position, Esaote is recognised for its unique blend of cutting-edge technology and user-friendly design, making it a trusted partner in the healthcare sector.
DitchCarbon Score
How does Esaote's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Esaote's score of 42 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Esaote's reported carbon emissions
In 2024, Esaote reported total carbon emissions of approximately 1,266,050 kg CO2e for Scope 1 and about 467,710 kg CO2e for Scope 2, resulting in a combined total of around 1,733,670 kg CO2e. This marks a slight decrease from 2023, when emissions were approximately 1,736,430 kg CO2e, with Scope 1 emissions at about 1,186,140 kg CO2e and Scope 2 at approximately 551,290 kg CO2e. Esaote has committed to a decarbonisation plan aimed at reducing emissions across all scopes, including Scope 1, 2, and 3, with a target timeframe from 2023 to 2025. This initiative reflects the company's dedication to achieving net-zero emissions in the near term, although specific percentage reduction targets have not been disclosed. The emissions data is not cascaded from any parent organisation, indicating that these figures are independently reported by Esaote S.p.A. The company continues to focus on sustainability and reducing its carbon footprint in the medical technology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 1,256,790 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 583,070 | 000,000 | 000,000 | 000,000 |
| Scope 3 | - | - | - | - |
How Carbon Intensive is Esaote's Industry?
How Carbon Intensive is Esaote's Location?
Esaote's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Esaote has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
